Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  European Journal of Pharmacology

• Publication date

  1989-01-10

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(89)90700-0PMID 2707305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonist

  1988cited by this paper
• Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors

  1988cited by this paper
• [3H]quaternised ICS 205-930 labels 5-HT3 receptor binding sites in rat brain.

  1988cited by this paper
• Similar effects of diazepam and the 5-HT3 receptor antagonist ICS 205-930 on place aversion conditioning.

  1988cited by this paper
• [3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes.

  1988cited by this paper
• Identification of 5‐HT3 recognition sites in human brain tissue using [3H]zacopride

  1988cited by this paper
• Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.

  1988cited by this paper
• Pharmacological characterization of 5‐hydroxytryptamine‐induced depolarization of the rat isolated vagus nerve

  1987cited by this paper
• Evidence for an extra-abdominal site of action for the 5-HT3 receptor antagonist BRL24924 in the inhibition of radiation-evoked emesis in the ferret.

  1987cited by this paper
• Identification of serotonin 5-HT3 recognition sites by radioligand binding in NG108-15 neuroblastoma-glioma cells.

  1987cited by this paper
• Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

  1987cited by this paper
• Antiemetic properties of the 5HT3-receptor antagonist, GR38032F.

  1987cited by this paper
• Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist.

  1987cited by this paper
• Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

  1987cited by this paper
• Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.

  1987cited by this paper
• Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonism

  1986cited by this paper
• The depolarizing action of 5‐hydroxytryptamine on rabbit vagal afferent and sympathetic neurones in vitro and its selective blockade by ICS 205–930

  1986cited by this paper
• 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis.

  1986cited by this paper
• Vergleichende Lokalisationslehre der Großhirnrinde : in ihren Prinzipien dargestellt auf Grund des Zellenbaues

  1985cited by this paper
• Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs

  1985cited by this paper
• Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum

  1985cited by this paper
• MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors

  1984cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

  1978cited by this paper
• MECHANISM OF THE INDIRECT SYMPATHOMIMETIC EFFECT OF 5‐HYDROXYTRYPTAMINE ON THE ISOLATED HEART OF THE RABBIT

  1976cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• New characterization of dihydroergotamine receptor pharmacology in the context of migraine: utilization of a β-arrestin recruitment assay

  2023cites this paper
• Gastrointestinal inflammation plays a critical role in chemotherapy-induced nausea and vomiting.

  2022cites this paper
• Autoradiographic labelling of 5-HT3 receptors in the hemi-parkinsonian rat brain.

  2021cites this paper
• Recent advances with 5-HT3 modulators for neuropsychiatric and gastrointestinal disorders.

  2020cites this paper
• Genetically Engineered Biomaterials

  2020cites this paper
• Distribution of 5-HT receptors in the central nervous system: an update

  2020cites this paper
• Serotonin neurobiology in cocaine use disorder

  2020cites this paper
• Stereological investigation of 5-HT3 receptors in the substantia nigra and dorsal raphe nucleus in the rat.

  2020cites this paper
• Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease.

  2020cites this paper
• Granisetron, a selective 5-HT3 antagonist, reduces L-3,4-dihydroxyphenylalanine-induced abnormal involuntary movements in the 6-hydroxydopamine-lesioned rat.

  2020cites this paper
• Discriminative Stimulus Effects of Psychostimulants.

  2018cites this paper
• Pharmacological Analysis in Favour of a Physiological Role for the Constitutive Activity of 5-HT 2A Receptors in Learning

  2018cites this paper
• Direct modification of the 5‐HT3 receptor current by some anticancer drugs

  2018cites this paper
• 5-HT2A Receptors in the Central Nervous System

  2018cites this paper
• TCB‐2 [(7R)‐3‐bromo‐2, 5‐dimethoxy‐bicyclo[4.2.0]octa‐1,3,5‐trien‐7‐yl]methanamine]: A hallucinogenic drug, a selective 5‐HT2A receptor pharmacological tool, or none of the above?

  2017cites this paper
• Building a 5-HT3A Receptor Expression Map in the Mouse Brain

  2017cites this paper
• Synthesis and Pharmacological Evaluation of [11C]Granisetron and [18F]Fluoropalonosetron as PET Probes for 5-HT3 Receptor Imaging.

  2016cites this paper
• Investigation of the allosteric pharmacology of the 5-HT\(_3\) receptor identifying the potent allosteric modulator 5-chloroindole

  2015cites this paper
• Tests for Anxiolytic Activity

  2015cites this paper
• The medical implications of gastrointestinal vagal afferent pathways in nausea and vomiting.

  2014cites this paper
• Mercaptoacetate and fatty acids exert direct and antagonistic effects on nodose neurons via GPR40 fatty acid receptors.

  2014cites this paper
• 5-Hydroxytryptamine–Mediated Neurotransmission Modulates Spontaneous and Vagal-Evoked Glutamate Release in the Nucleus of the Solitary Tract Effect of Uptake Blockade

  2014cites this paper
• 5-hydroxytryptamine mediated neurotransmission modulates spontaneous and vagal evoked glutamate release in the nucleus tractus solitary (NTS) - effect of uptake blockade

  2014influential citation
• Mental Health Retrosight

  2013cites this paper
• Identification of unique release kinetics of serotonin from guinea‐pig and human enterochromaffin cells

  2013cites this paper
• Subunit‐dependent inhibition and potentiation of 5‐HT3 receptor by the anticancer drug, topotecan

  2013cites this paper
• Serotonergic control of the developing cerebellum

  2013influential citation
• Mental Health Retrosight: Final report on Phase I

  2012cites this paper
• Chemotherapy-induced nausea and vomiting: optimizing prevention and management.

  2012cites this paper
• The Possible Role of Gonadal Steroids and 5HT 3 Receptors in Encouraging

  2012cites this paper
• The Possible Role of Gonadal Steroids and 5HT3 Receptors in Encouraging Menses

  2012cites this paper
• Presynaptic control of serotonin on striatal dopamine function

  2011cites this paper
• Transient expression of functional serotonin 5‐HT3 receptors by glutamatergic granule cells in the early postnatal mouse cerebellum

  2011influential citation
• Role of 5-HT3 Receptors in the Antidepressant Response

  2011influential citation
• Clinical roundtable monograph. Treatment of chemotherapy-induced nausea and vomiting: a post-MASCC 2010 discussion.

  2011cites this paper
• Distribution of 5-HT Receptors in the Central Nervous System

  2010cites this paper
• [Pharmacological, pharmacokinetic, and clinical profile of palonosetron hydrochloride (ALOXI I.V. Injection 0.75 mg), a novel antiemetic 5-HT3-receptor antagonist].

  2010cites this paper
• Immunohistochemical characterization of 5-HT3A receptors in the Syrian hamster forebrain

  2010cites this paper
• Activation of 5-HT3 receptors leads to altered responses 6 months after MDMA treatment

  2010cites this paper
• Intragastric monosodium L-glutamate stimulates motility of upper gut via vagus nerve in conscious dogs.

  2010cites this paper
• Neural pathways and cellular mechanisms of mercaptoacetate

  2010cites this paper
• Management der Chemotherapie-induzierten Emesis: Was ist Standard nach 20 Jahren klinischer Forschung?

  2009cites this paper
• Brain Fos expression induced by the chemotherapy agent cisplatin in the rat is partially dependent on an intact abdominal vagus.

  2009cites this paper
• Gingerol inhibits cisplatin-induced vomiting by down regulating 5-hydroxytryptamine, dopamine and substance P expression in minks

  2009cites this paper
• Characteristics for Enhanced Response of Serotonin-Evoked Ion Dynamics in Differentiated NG108-15 Cells

  2009cites this paper
• A new approach for exploring functional development of fetal brain pathways.

  2009cites this paper
• Use of acupuncture in the control of chemotherapy-induced nausea and vomiting.

  2009cites this paper
• Chemotherapy-induced nausea and vomiting.

  2008cites this paper
• Drug Therapy Chemotherapy-Induced Nausea and Vomiting

  2008cites this paper
• Pharmacology of vagal afferent influences on disordered breathing during sleep.

  2008influential citation
• Serotonin receptors.

  2008cites this paper
• Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5‐HT3 receptor antagonist: a pilot study

  2008cites this paper
• Efectos de la cocaína en el ser humano

  2008cites this paper
• Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

  2007cites this paper
• BASES NEUROANATÓMICAS, NEUROBIOLÓGICAS Y DEL APRENDIZAJE DE LA CONDUCTA DE ADICCIÓN A LA COCAÍNA

  2007cites this paper
• Identification of an immune-responsive mesolimbocortical serotonergic system: Potential role in regulation of emotional behavior

  2007cites this paper
• The Serotonin Receptors

  2006cites this paper
• Evidence for a vagal pathophysiology for bulimia nervosa and the accompanying depressive symptoms.

  2006cites this paper
• Chemical Neuroanatomy of 5-HT Receptor Subtypes in the Mammalian Brain

  2006cites this paper
• Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis.

  2006cites this paper
• Effects of the 5‐HT3 receptor antagonist, alosetron, in a rat model of somatic and visceral hyperalgesia

  2006cites this paper
• Distribution and morphology of serotonin-immunoreactive axons in the retrohippocampal areas of the New Zealand white rabbit

  2005cites this paper
• Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists

  2005cites this paper
• Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse

  2005cites this paper
• Characterisation of c-Fos expression in the central nervous system of mice following right atrial injections of the 5-HT3 receptor agonist phenylbiguanide.

  2005cites this paper
• Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding

  2005cites this paper
• Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal

  2005cites this paper
• The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system

  2005cites this paper
• Aprepitant (EMEND)

  2005cites this paper
• Influence of sodium substitutes on 5‐HT‐mediated effects at mouse 5‐HT3 receptors

  2004cites this paper
• Synaptic inputs to trigeminal primary afferent neurons cause firing and modulate intrinsic oscillatory activity.

  2004cites this paper
• Serotonin 5-HT(3) receptor mediation of pain and anti-nociception: implications for clinical therapeutics.

  2004cites this paper
• Central Modulation of Rectal Distension-Induced Blood Pressure Changes by Alosetron, A 5-HT3 Receptor Antagonist

  2004cites this paper
• Treatment Options for Chemotherapy-Induced Nausea and Vomiting

  2003cites this paper
• Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol

  2003cites this paper
• Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists.

  2003cites this paper
• Pharmacological Profile of AS-9705, a Novel Benzotriazolecarboxamide Derivative, as a Gastroprokinetic Agent with Potent Anti-emetic Activity

  2003cites this paper
• Roles of substance P and NK(1) receptor in the brainstem in the development of emesis.

  2003cites this paper
• Differential induction of c-fos expression in brain nuclei by noxious and non-noxious colonic distension: role of afferent C-fibers and 5-HT3 receptors.

  2003cites this paper
• Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity.

  2003cites this paper
• Differential Composition of 5-Hydroxytryptamine3Receptors Synthesized in the Rat CNS and Peripheral Nervous System

  2002cites this paper
• Synthesis of optically active af-(1-Ethyl-3-methylhexahydro-1,3-diazin-5-yl)- and N-(1-Ethyl-5-methyloctahydro-1,5-diazocin-3-yl)pyridine-3-carboxamides

  2002cites this paper
• Nausea and vomiting after laparoscopic surgery are not associated with an increased peripheral release of serotonin

  2002cites this paper
• Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron.

  2002cites this paper
• The effect of the 5‐HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients

  2002cites this paper
• Distribution of [3H]GR65630 Binding in Human Brain Postmortem

  2001cites this paper
• Distribution of serotonin 2A, 2C and 3 receptor mRNA in spinal cord and medulla oblongata.

  2001cites this paper
• Roles of 5-HT receptors in the release and action of secretin on pancreatic secretion in rats.

  2001cites this paper
• Central antiemetic effects of AS-8112, a dopamine D2, D3, and 5-HT(3) receptor antagonist, in ferrets.

  2001cites this paper
• Synthesis and characterization of photolabile derivatives of serotonin for chemical kinetic investigations of the serotonin 5-HT(3) receptor.

  2000cites this paper
• Nitrogen‐containing heteroalicycles with serotonin receptor binding affinity: Development of gastroprokinetic and antiemetic agents

  1999cites this paper
• Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT3 receptor antagonist

  1999cites this paper
• Intragastric Capsaicin Stimulates Motility of Upper Gut and Proximal Colon via Distinct Pathways in Conscious Dogs

  1999cites this paper
• Pharmacokinetics of granisetron in rat blood and brain by microdialysis.

  1999cites this paper
• The herbal medicine Dai-Kenchu-Tou stimulates upper gut motility through cholinergic and 5-hydroxytryptamine 3 receptors in conscious dogs.

  1999cites this paper
• Central methysergide prevents renal sympathoinhibition and bradycardia during hypotensive hemorrhage.

  1998cites this paper
• 5-hydroxytryptamine3 (5-HT3) receptor-mediated depolarisation of the rat isolated vagus nerve: modulation by trichloroethanol and related alcohols.

  1998cites this paper
• A novel series of N-(hexahydro-1,4-diazepin-6-yl) and N-(hexahydroazepin- 3-yl)benzamides with high affinity for 5-HT3 and dopamine D2 receptors.

  1998cites this paper
• The Central 5-HT3 Receptor in CNS Disorders

  1998cites this paper
• [Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research].

  1998cites this paper